Can you believe BROMSITE received compensation for the extended wait time during the regulatory approval process?
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8778999 | SUN PHARM | Non-steroidal anti-inflammatory ophthalmic compositions |
Aug, 2029
(5 years from now) | |
Bromsite is owned by Sun Pharm.
Bromsite contains Bromfenac Sodium.
Bromsite has a total of 1 drug patent out of which 0 drug patents have expired.
Bromsite was authorised for market use on 08 April, 2016.
Bromsite is available in solution/drops;ophthalmic dosage forms.
Bromsite can be used as treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.
The generics of Bromsite are possible to be released after 07 August, 2029.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Apr 08, 2019 |
Drugs and Companies using BROMFENAC SODIUM ingredient
Market Authorisation Date: 08 April, 2016
Treatment: Treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery
Dosage: SOLUTION/DROPS;OPHTHALMIC
How can I launch a generic of BROMSITE before it's drug patent expiration?
More Information on Dosage
BROMSITE family patents
